FSA
AXSM icon

Franklin Street Advisors’s Axsome Therapeutics AXSM Stock Holding History

Franklin Street Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$1.69M – 172
2026
Q1 		$1.69M Hold
10,000
– – 0.1% 67
2025
Q4 		$1.83M Buy
+10,000
New +$1.4M 0.1% 67

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
CA
Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Franklin Street Advisors's AXSM Position: Q2 2026 in Review

Franklin Street Advisors sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 10,000 shares — an estimated $1.69M sold.

Franklin Street Advisors first reported a position in AXSM in Q4 2025 and held it in 2 quarters. The position peaked at $1.83M in Q4 2025. 38 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Franklin Street Advisors reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Franklin Street Advisors sold 10,000 Axsome Therapeutics shares in Q2 2026, an estimated $1.69M.
  • Franklin Street Advisors first reported a position in Axsome Therapeutics in Q4 2025 and held it in 2 quarters.
  • Franklin Street Advisors's Axsome Therapeutics position peaked at $1.83M in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.